J075-2199 Screening compound: N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[5-(propan-2-yl)-1,2,4-oxadiazol-3-yl]benzamide

J075-2199 Screening compound: N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[5-(propan-2-yl)-1,2,4-oxadiazol-3-yl]benzamide
J075-2199 Screening compound: N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[5-(propan-2-yl)-1,2,4-oxadiazol-3-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J075-2199
N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[5-(propan-2-yl)-1,2,4-oxadiazol-3-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J075-2199

Molecular Formula

C21H18FN5O3 (C21 H18 FN5 O3)

Compound Name

N-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[5-(propan-2-yl)-1,2,4-oxadiazol-3-yl]benzamide

IUPAC name

N-{[5-(4-fluorophenyl)-124-oxadiazol-3-yl]methyl}-4-[5-(propan-2-yl)-124-oxadiazol-3-yl]benzamide

SMILES

CC(C)c1nc(-c(cc2)ccc2C(NCc2noc(-c(cc3)ccc3F)n2)=O)no1

InChI

InChI=1S/C21H18FN5O3/c1-12(2)20-25-18(27-29-20)13-3-5-14(6-4-13)19(28)23-11-17-24-21(30-26-17)15-7-9-16(22)10-8-15/h3-10,12H,11H2,1-2H3,(H,23,28)

InChI Key

CTXFYAYLECIYMI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27223430

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.4

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.637

Distribution Coefficient, logD

4.637

Water Solubility, LogSw

-4.34

Polar Surface Area

88.997

Acid Dissociation Constant (pKa)

12.65

Base Dissociation Constant (pKb)

-3.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

J075-2199 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Anti-Aging Library (44940 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR
  • Phosphatases

References: we are preparing a list of scientific research reports with J075-2199 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J075-2199?
Check Price and Availability of J075-2199, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J075-2199 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J075-2199
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J075-2199
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J075-2199 available by request